Why is €2 billion worth of COVID drug Paxlovid going to waste?

European countries rushed to buy the antiviral drug in January 2022, but now it’s going to waste. Why? A COVID-19 antiviral drug has been underused in Europe with about 3.1 million courses of the medicine set to expire in the UK, Germany, Spain, Italy, and France by the end of this month. With…#spain #airfinity #pfizer #marcogallotta #lifescienceanalyst #euronewshealth #gallota #pbs #askojärvinen #hus
Source: Reuters: Health - Category: Consumer Health News Source Type: news